The Enterprise Value as of November 2024 (TTM) for AXIM Biotechnologies, Inc. (AXIM) is 7.85M

According to AXIM Biotechnologies, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 7.85M. This represents a change of -22.71% compared to the average of 10.16M of the last 4 quarters.

AXIM Biotechnologies, Inc. (AXIM) Historical Enterprise Value (quarterly & annually)

How has AXIM Enterprise Value performed in the past?

The mean historical Enterprise Value of AXIM Biotechnologies, Inc. over the last ten years is 141.64M. The current 7.85M Enterprise Value has changed 454.34% with respect to the historical average. Over the past ten years (40 quarters), AXIM's Enterprise Value was at its highest in in the March 2017 quarter at 707.27M. The Enterprise Value was at its lowest in in the March 2024 quarter at 9.28M.

AXIM Biotechnologies, Inc. (AXIM) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of AXIM Biotechnologies, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

AXIM Biotechnologies, Inc. (AXIM) Average Enterprise Value

How has AXIM Enterprise Value performed in the past?

The current Enterprise Value of AXIM Biotechnologies, Inc. (AXIM) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

AXIM Biotechnologies, Inc. (AXIM) Enterprise Value vs. Peers

How is AXIM’s Enterprise Value compared to its peers?

AXIM Biotechnologies, Inc.’s Enterprise Value is less than Cellectis S.A. (144.28M), less than Biotron Limited (19.47M), greater than Regenicin, Inc. (15.35K), less than Bioasis Technologies Inc. (39.54M), less than Adynxx, Inc. (0), greater than Ascletis Pharma Inc. (581.00), less than Wesana Health Holdings Inc. (753.62M), greater than BioVaxys Technology Corp. (358.19K), less than GH Research PLC (18.81M), less than Algernon Pharmaceuticals Inc. (329.85M), greater than Mindset Pharma Inc. (1.23M), less than Biostage, Inc. (68.66M), less than BioCardia, Inc. (57.66M), less than AVAX Technologies, Inc. (8.05M), greater than null (-5834264.00),

Build a custom stock screener for AXIM Biotechnologies, Inc. (AXIM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AXIM Biotechnologies, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

AXIM Biotechnologies, Inc. (AXIM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like AXIM Biotechnologies, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.